Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

1.23
-0.0400-3.15%
Post-market: 1.230.00000.00%19:56 EDT
Volume:2.56M
Turnover:3.15M
Market Cap:272.91M
PE:-1.11
High:1.27
Open:1.26
Low:1.21
Close:1.27
52wk High:3.78
52wk Low:0.8621
Shares:221.88M
Float Shares:164.98M
Volume Ratio:0.64
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1091
EPS(LYR):-1.3222
ROE:-55.12%
ROA:-26.98%
PB:0.79
PE(LYR):-0.93

Loading ...

Oct 11, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 23, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Apr 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities